Navigation Links
Prescient Medical Achieves Milestones in Clinical Studies of vProtect(TM) Luminal Shield
Date:3/4/2009

100% Technical Success, No Peri-procedural Complications Reported With Coronary Device

DOYLESTOWN, Pa., March 4 /PRNewswire/ -- Prescient Medical, Inc. reached a crucial milestone in February by completing the enrollment of 30 patients in the first phase of its first-in-human clinical trial for the vProtect(TM) Luminal Shield, conducted at the Corbic Research Institute in Colombia. The Shield successfully crossed all target lesions and was safely implanted in all 30 patients, with a technical success rate of 100%. No procedural or in-hospital complications were reported for any of the patients. The patients enrolled in the study had non-calcified lesions in coronary arteries, lesions that would normally be treated with traditional balloon-expandable stents.

No major adverse coronary events (MACE) were reported at 30 days post-implant in the 28 patients who had reached that milestone. Nine-month angiographic follow-up was reported for 2 initial patients; there was no evidence of significant neointimal growth in these patients. "We are very pleased with the performance of the Shield in this preliminary study. We have achieved an excellent technical result, and soon we will know more about clinical outcomes with the Shield," said co-principal investigator Juan A. Delgado, MD of Corbic Research Institute.

Prescient Medical has also broken new ground with a study evaluating use of the vProtect(TM) Luminal Shield in non-obstructive "vulnerable plaque" lesions that may rupture and cause acute myocardial infarction. According to Dr. Delgado, "The self-expanding Shield is designed to deploy with less injury to the artery, which should reduce neointimal overgrowth compared with currently marketed bare metal stents. We think these properties make the Shield a promising treatment to stabilize vulnerable plaque and prevent major events like heart attacks."

About Prescient Medical, Inc.


'/>"/>
SOURCE Prescient Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Prescient Medical, Inc. Achieves Successful Clinical Debut of vProtect(TM) Luminal Shield
2. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
3. Impact Medical Solutions Announces Initiation of Pilot Clinical Trial and Listing on Frankfurt Stock Exchange
4. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
5. Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test
6. Foreign Medical Devices are in High Demand in Russia
7. Oridion Announces Significant Medical Studies Presented at STA
8. AGA Medical Corporation Launches Web-Based Stroke Education and Awareness Program Featuring Professional Football Player Tedy Bruschi
9. Impact Medical Solutions Announces Appointment of New Director and Corporate Update
10. Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
11. ProUroCare Medical Inc. Announces Pricing of Equity Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 2014 /CNW/ - T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or ... quality medical marijuana products, is pleased to announce that ... signed a definitive lease agreement for a second facility ... facility has 28,966 square feet of floor space with ... mezzanine space for a total of approximately 43,500 square ...
(Date:9/22/2014)... Sept. 22, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: CMN ... fiscal 2014 ended July 31, 2014 on Monday, September 29 ... discuss the results at 11:00 AM ET. Participating in the ... Andrew A. Krakauer , President and CEO; Jorgen B. ... Sheldon , Senior Vice President, CFO and Treasurer; and ...
(Date:9/22/2014)... , Sept. 22, 2014  Olympus, a global ... for medical and surgical procedures, among other core ... with Munich -based Brainlab to ... Navigation. This agreement applies to the US ... U.S. sales and all distribution outside the U.S. ...
Breaking Medicine Technology:T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 2T-Bird Pharma Inc. to Increase Growing Capacity with Expansion into a 43,500 square feet Second Facility 3Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Fourth Quarter And Fiscal 2014 Ended July 31, 2014 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 4
(Date:9/22/2014)... 22, 2014 (HealthDay News) -- New research raises doubts ... cancer. Smokers with cancer who used e-cigarettes along ... those who didn,t use the devices, a Memorial Sloan ... likely -- or less likely -- to have quit ... The study, published online Sept. 22 in Cancer ...
(Date:9/22/2014)... Montreal, Quebec (PRWEB) September 22, 2014 ... understanding of chronic myelogenous leukemia, a form of blood ... CML is caused by a mutation affecting chromosomes 22 ... become a powerful symbol as the worldwide community unites ... it affects. , CML is at the forefront of ...
(Date:9/22/2014)... York, NY (PRWEB) September 22, 2014 ... City, has just posted a new article to its ... feel more than just a tad dismayed. Titled “Coffee ... article, http://www.lifeant.com/coffee-drinkers-beware-paying-life-insurance/ states on average, coffee fans ... premiums than those who do not enjoy the tasty ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 As football season ... starting to put together their fantasy football leagues to prep ... also prepping as they work on new ways to bring ... Mica Lounge, located in the Sheraton Silver Spring Hotel, is ... own “Sheraton League” where locals and hotel guests can sign ...
(Date:9/22/2014)... New York, NY (PRWEB) September 22, 2014 ... - Dr. Beth Schrope , NewYork-Presbyterian/Columbia University ... or auto islet surgery, to prevent diabetes in ... is the first center in the New York ... Every year, roughly 87,000 people in the United ...
Breaking Medicine News(10 mins):Health News:E-Cigarettes Don't Help Cancer Patients Quit Smoking: Study 2Health News:Marking World CML Day on September 22nd 2Health News:Marking World CML Day on September 22nd 3Health News:Coffee Drinkers Are Charged More For Life Insurance, Reports LifeAnt.com 2Health News:Sheraton Silver Spring Hotel Keeps Football Fans Engaged Online and in their Lounge 2Health News:Sheraton Silver Spring Hotel Keeps Football Fans Engaged Online and in their Lounge 3Health News:Sheraton Silver Spring Hotel Keeps Football Fans Engaged Online and in their Lounge 4Health News:New Treatment May Prevent Diabetes After Pancreatitis Surgery 2Health News:New Treatment May Prevent Diabetes After Pancreatitis Surgery 3
... A new study investigating the potential beneficial effects ... of anti-TNFa treatment in aging," appears in the ... ,This study shows hope for significantly ... been linked to blood vessel dysfunction and cell ...
... to your high blood pressure might just be your ... evidence suggests that inflammation, a part of the immune ... diabetes, may also help translate stress into high blood ... is an inflammatory condition,” says Dr. Haidong Zhu, molecular ...
... reduction pill, which works better and faster than existing drugs// ... and cancer. ,Existing anti-obesity pills generally cut weight ... ,But men and women taking Excalia, the new ... lost 12 percent of their body weight, according to the ...
... undergo a double hand transplant was ecstatic as she got ... "I'm doing very well, I'm very happy. I'm taking steps ... life. When I saw the hands after the operation, they ... her arms following an explosion in a laboratory in 1978, ...
... better safety for patients in ICU by adhering to ... threatening// catheter-related infections. ICUs can become thoroughly aseptic by ... syringes and catheters. A detailed report was made by ... of the report are published in New England Journal ...
... more people succumbed to Rift Valley Fever in Garissa district, ... has been made by the North Eastern Provincial// Medical Officer ... cautioned the public to seek medical attention as quickly as ... the disease is due to lack of awareness. But local ...
Cached Medicine News:Health News:Effects Of Age-related Vascular Diseases Can Be Reduced By Inactivating TNFa 2Health News:Inflammatory Genes Linked to Salt-Sensitive Hypertension 2Health News:Inflammatory Genes Linked to Salt-Sensitive Hypertension 3Health News:Simple Steps to Safe Guard Patients from Bloodstream Infections in ICU 2
Recommended to insert plug portion of all monocanalicular intubation systems into punctum....
Skin Tone External Eyelid Weights...
To prevent retraction of the conjunctival cul-de-sacs without touching the cornea....
Bioceramic orbital implants insert easily into orbital socket and will not cling to surrounding tissue. Improved interconnectivity between pores enhances vascularization. Implants may be easily drill...
Medicine Products: